[Etiology and therapy of insulin resistance].
Kasuga
M
M
Hunabiki
A
A
Morita
S
S
D000818:Animals; D001161:Arteriosclerosis / Q000503:physiopathology; D001645:Biguanides / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D006801:Humans; D006949:Hyperlipidemias / Q000503:physiopathology; D006973:Hypertension / Q000503:physiopathology; D007333:Insulin Resistance; D008019:Life Style; D009765:Obesity; D012307:Risk Factors; D013844:Thiazoles / Q000627:therapeutic use; D045162:Thiazolidinediones; D014409:Tumor Necrosis Factor-alpha
D001645:Biguanides; D013844:Thiazoles; D045162:Thiazolidinediones; D014409:Tumor Necrosis Factor-alpha; C089946:2,4-thiazolidinedione